Genflow Biosciences plc (LON:GENF – Get Free Report) fell 3.7% on Thursday . The stock traded as low as GBX 1.86 and last traded at GBX 1.95. Approximately 6,609,427 shares traded hands during trading, an increase of 208% from the average daily volume of 2,142,671 shares. The stock had previously closed at GBX 2.02.
Genflow Biosciences Stock Performance
The company has a market cap of £11.04 million, a PE ratio of -5.87 and a beta of 2.29. The company has a fifty day moving average of GBX 2.01 and a two-hundred day moving average of GBX 2.08.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
See Also
- Five stocks we like better than Genflow Biosciences
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
